Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation.
Saved in:
| Title: | Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation. |
|---|---|
| Authors: | Zhang C; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Liu J; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Gu T; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Meng X; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Cai X; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Zhang J; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Chen Y; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Zhang D; Department of Orthopaedic, The First Hospital of Jilin University, Changchun, China. zhangdg@jlu.edu.cn., Wu Y; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China. ygwu@jlu.edu.cn. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Jun; Vol. 211 (3), pp. 637-648. Date of Electronic Publication: 2025 Mar 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
